Evidence that vasoactive intestinal polypeptide is a parasympathetic neurotransmitter in the endocrine pancreas in dogs

Regulatory Peptides

Volumn 71, Issue 3, 1997, Pages 163-170

  Havel, Peter J ^a   Dunning, Beth E ^b   Verchere, C Bruce ^c   Baskin, Denis G ^c   O'Dorisio, Thomas ^d   Taborsky Jr, Gerald J ^c  

^a Physiol   (United States)

^b Sandoz Pharma Ltd   (Switzerland)

^c UNIVERSITY OF WASHINGTON   (United States)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Acetylcholine; Atropine; Glucagon; Hexamethonium; Insulin; Somatostatin

Indexed keywords

NEUROTRANSMITTER; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DOG; ELECTROSTIMULATION; GANGLION BLOCK; HORMONE DETERMINATION; HORMONE RELEASE; NEUROTRANSMISSION; NONHUMAN; PANCREAS ISLET; PARASYMPATHETIC NERVE; PRIORITY JOURNAL; PROTEIN DETERMINATION; VAGUS NERVE STIMULATION;

ANIMALS; ATROPINE; DOGS; ELECTRIC STIMULATION; GANGLIA, PARASYMPATHETIC; HEXAMETHONIUM; MUSCARINIC ANTAGONISTS; NERVE FIBERS; NEUROTRANSMITTER AGENTS; NICOTINIC ANTAGONISTS; PANCREAS; STAINING AND LABELING; VASOACTIVE INTESTINAL PEPTIDE;

ANIMALIA; CANIS FAMILIARIS;

EID: 0030874129     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(97)01014-8     Document Type: Article

References (42)

1. Johnson LR, Regulation: Peptides in the gastrointestinal tract. In Johnson LR, editor. Gastrointestinal Physiology, St. Louis: Mosby Year Book, 1991: 1-15.
2. Ahren B., Taborsky G.J. Jr. The mechanism of vagal nerve stimulation of glucagon and insulin secretion in the dog. Endocrinology. 118:1986;1551-1557.
3. Hoist J.J., Gronholt T., Schaffalitzky de Muckadell O.B., Fahrenkrug J. Nervous control of pancreatic endocrine secretion in pigs II. The effect of pharmacological blocking agents on the response to vagal nerve stimulation. Acta Physiol. Scand. 111:1981;9-14.
4. Nishi S., Seino Y., lshida H., Seno M., Taminato T., Sakurai H., Imura H. Vagal regulation of insulin, glucagon, and somatostatin secretion in vitro in the rat. J. Clin. Invest. 79:1987;1191-1196.
5. Ahren B., Taborsky G.J. Jr., Porte D. Jr. Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion. Diabetologia. 29:1986;827-836.
6. Havel P.J., Taborsky Jr G.J. The contribution of the autonomic nervous system to changes of glucagon and insulin secretion during hypoglycemic stress. Endocrine Rev. 10:1989;332-350.
7. Larsson L.I., Fahrenkrug J., Hoist J.J., Schaffalitzky de Muckadeli O.B. Innervation of the pancreas by vasoactive intestinal polypeptide (VIP) immunoreactive nerves. Life Sci. 22:1978;773-779.
8. Bishop A.E., Polak J.M., Green I.C., Bryant M.G., Bloom S.R. The location of VIP in the pancreas of man and rat. Diabetologia. 18:1980;73-78.
9. Prinz R.A., El Sabbagh H., Adrian T.E., Bloom S.R., Gardner I., Polak J.M., lnokuchi H., Bishop A.E., Welbourn R.B. Neural regulation of pancreatic polypeptide release. Surgery. 94:1983;1011-1018.
10. Hoist J.J., Fahrenkrug J., Knuhtsen S., Jensen S.L., Nielsen O.V., Lundberg J.M., Hokfelt T. VIP and PHI in the pig pancreas: coexistence, corelease, and cooperative effects. Am. J. Physiol. 252:1987;G182-G189.
11. Huchtebrock H.-J., Niebel W., Singer M.V., Forssmann W.G. Intrinsic pancreatic nerves after mechanical denervation of the extrinsic pancreatic nerves in dogs. Pancreas. 6:1991;1-8.
12. Fahrenkrug J., Hoist Pedersen J., Yamashita Y., Ottesen B., Hokfelt T., Lundberg J.M. Occurrence of VIP and peptide HM in human pancreas and their influence on pancreatic endocrine secretion in man. Regul. Pept. 18:1987;51-61.
13. Marongiu L., Perra M.T., Pinna A.D., Sidgu F., Sirigu P. Peptidergic (VIP) nerves in normal human pancreas and pancreatitis: an immunohistochemical study. Histol. Histopathol. 8:1993;127-132.
14. Baskin D.G., Gorray K., Fujimoto W. lmmunocytochemical detection of B cells in the guinea pig pancreas using guinea pig antiserum to porcine insulin. J. Histochem. Cytochem. 29:1981;567-571.
15. Li L., Jiang J., Hagopian W.A., Kadsen A.E., Skelly M., Baskin D.G., Lernmark A. Differential expression of rat islet and brain glutamic acid decarboxylase (GAD) isoforms using sequence-specific peptide antibodies. J. Histochem. Cytochem. 43:1995;53-59.
16. Havel P.J., Paquette T.L., Taborsky G.J. Jr. Halothane is less suppressive than pentobarbital on reflex and neural activation of the pancreatic F-cell. Am. J. Physiol. 251(Endocrinol. Metab. Physiol. 14):1986;E111-E116.
17. Havel P.J., Veith R.C., Dunning B.E., Taborsky G.J. Jr. A role for the autonomic nervous system to increase glucagon secretion during marked hypoglycemia in dogs. Diabetes. 40:1991;1107-1114.
18. Havel P.J., Veith R.C., Dunning B.E., Taborsky G.J. Jr. Pancreatic noradrenergic nerves are activated by neuroglucopenia but not by hypotension or hypoxia in the dog: Evidence for stress-specific and regionally selective activation of the sympathetic nervous system. J. Clin. Invest. 82:1988;1538-1545.
19. Havel P.J., Mundinger T.O., Veith R.C., Dunning B.E., Taborsky G.J. Jr. Co-release of galanin and NE from pancreatic sympathetic nerves during severe insulin-induced hypoglycemia in dogs. Am. J. Physiol. 263(Endocrine. Metab. Physiol. 26):1992;E8-E16.
20. Dunning B.E., Havel P.J., Taborsky G.J. Surgical separation of the pancreas and duodenum eliminates the endocrine pancreatic response to vagal stimulation. Diabetes. 36(Suppl. 1):1987;94A.
21. Ahren B., Paquette T.L., Taborsky G.J. Jr. Effect and mechanism of vagal nerve stimulation on somatostatin secretion in dogs. Am. J. Physiol. 250(Endocrine. Metab. Physiol. 13):1986;E212-E217.
22. DeHaen C., Little S.A., May J.M., Williams R.H. Characterization of proinsulin-insulin intermediates in human plasma. J. Clin. Invest. 62:1978;7272-7277.
23. Tager H.A., Hohenboken M., Markese J. High titer glucagon antisera. Endocrinology. 100:1977;367-372.
24. Morgan C.R., Lazarow A. lmmunoassay of insulin: two antibody system. Plasma insulin of normal, subdiabetic, and diabetic rats. Diabetes. 12:1963;115.
25. Conlon J.M., Bridgeman M., Alberti K.G.M.M. The nature of big plasma somatostatin: implications for the measurement of somatostatin-like immunoreactivity in human plasma. Anal. Biochem. 125:1982;243-252.
26. O'Dorisio T.M., Howe B.A., Hill D.S., Obermeyer J., Cataland S. Vasoactive intestinal polypeptide (VIP) and neurotensin radioimmunoassays. J. Clin. Immunoassay. 10:1987;85-90.
27. Ahren B., Dunning B.E., Havel P.J., Veith R.C., Taborsky G.J. Extraction of epinephrine and norepinephrine by the dog pancreas in vivo. Metabolism. 37:1988;68-73.
28. Dunning B.E., Havel P.J., Veith R.C., Taborsky G.J. Jr. Pancreatic and extrapancreatic galanin release during sympathetic neural activation. Am. J. Physiol. 258(Endocrinol. Metab. Physiol. 21):1990;E436-E444.
29. Miller R.E. Pancreatic neuroendocrinology: peripheral neural mechanisms in the regulation of the islets of Langerhans. Endocrine Rev. 2:1981;471-494.
30. Stjame L., Msghina M., Stjame E. Is 'upstream' control of sympathetic transmitter release dependent on the length of varicosity strings? Acta Physiol. Scand. 137:1989;313-314.
31. Prince F.P. Ultrastructural evidence of indirect and direct autonomic innervation of human Leydig cells: comparison of neonatal, childhood and pubertal ages. Cell Tiss. Res. 269:1992;383-390.
32. Smolen A.J. Morphology of synapses in the autonomic nervous system. J. Electron Microscopy Tech. 10:1988;187-204.
33. Bloom S.R., Edwards A.V. Pancreatic endocrine responses to stimulation of the peripheral ends of the vagus nerves in conscious calves. J. Physiol. 315:1981;31-41.
34. Lindkaer S., Jensen J., Fahrenkrug J., Hoist J.J., Nielsen O.V., Schaffalitzky de Muckadell O.B. Secretory effects of VIP on isolated perfused porcine pancreas. Am. J. Physiol. 235(Endocrine Metab. Physiol. 4):1978;E387-E391.
35. Karlsson S., Ahren B. Peptide receptor antagonists in the study of insulin and glucagon secretion in the mouse. Eur. J. Pharmacol. 191:1990;457-464.
36. Havel P.J., Parry S.J., Curry D.L., Akpan J.O., Stem J.S., Gingerich R.L. Autonomic nervous system mediation of the pancreatic polypeptide response to insulin-induced hypoglycemia in conscious rats. Endocrinology. 130:1992;2225-2229.
37. Havel P.J., Akpan J.O., Curry D.L., Stem J.S., Gingerich R.L., Ahren B. Autonomic control of pancreatic polypeptide and glucagon secretion during neuroglucopenia and hypoglycemia in mice. Am. J. Physiol. 265(Regulatory Integrative Comp. Physiol. 34):1993;R246-R254.
38. Havel PJ, Taborsky GJ, Jr. The contribution of the autonomic nervous system to increased glucagon secretion during hypoglycemic stress: Update 1994. In: Negro-Vilar A, Underwood LE, editors. The Endocrine Pancreas, Insulin Action, and Diabetes, Endocrine Reviews Monographs, Bethesda MD: Endocrine Society Press, 1994: 201-204.
39. Havel P.J., Parry S.J., Stem J.S., Akpan J.O., Gingerich R.L., Taborsky G.J. Jr., Curry D.L. Redundant parasympathetic and sympathoadrenal mediation of the glucagon response to insulin-induced hypoglycemia in conscious rats. Metabolism. 43:1994;860-866.
40. Havel P.J., Mundinger T.0., Taborsky G.J. Jr. Pancreatic sympathetic nerves contribute to increased glucagon secretion during severe hypoglycemia in dogs. Am. J. Physiol. 270(Endocrine Metab. Physiol. 33):1996;E20-E26.
41. Havel P.J., Valverde C. Autonomic mediation of glucagon secretion during insulin-induced hypoglycemia in rhesus monkeys. Diabetes. 45:1996;960-966.
42. Havel PJ, Ahren B. Activation of autonomic nerves and the adrenal medulla contributes to increased glucagon secretion during moderate insulin-induced hypoglycemia in women. Diabetes 1997;46:801-7.